Aspirin and recurrent venous thromboembolism
暂无分享,去创建一个
[1] S. Adams. Low-Dose Aspirin for Preventing Recurrent Venous Thromboembolism , 2013 .
[2] P. Prandoni,et al. Aspirin and recurrent venous thromboembolism in patients with symptomatic atherosclerosis: retrospective cohort study , 2012, Journal of thrombosis and haemostasis : JTH.
[3] W. Ageno,et al. Aspirin for preventing the recurrence of venous thromboembolism. , 2012, The New England journal of medicine.
[4] P. Prandoni,et al. Venous Thromboembolism and Arterial Complications , 2012, Seminars in Respiratory and Critical Care Medicine.
[5] Yngve Falck-Ytter,et al. Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. , 2012, Chest.
[6] Michael K Gould,et al. Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. , 2012, Chest.
[7] Paolo Prandoni,et al. Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. , 2012, Chest.
[8] Elie A Akl,et al. Prevention of VTE in Nonsurgical Patients Antithrombotic Therapy and Prevention of Thrombosis , 9 th ed : American College of Chest Physicians Evidence-Based Clinical Practice Guidelines , 2013 .
[9] J. Eikelboom,et al. Effectiveness and safety of combined antiplatelet and anticoagulant therapy: a critical review of the evidence from randomized controlled trials. , 2011, Blood reviews.
[10] Bruce L Davidson,et al. Oral rivaroxaban for symptomatic venous thromboembolism. , 2010, The New England journal of medicine.
[11] P. Wells,et al. Systematic Review: Case-Fatality Rates of Recurrent Venous Thromboembolism and Major Bleeding Events Among Patients Treated for Venous Thromboembolism , 2010, Annals of Internal Medicine.
[12] Georg Heinze,et al. Risk Assessment of Recurrence in Patients With Unprovoked Deep Vein Thrombosis or Pulmonary Embolism: The Vienna Prediction Model , 2010, Circulation.
[13] A. Tosetto,et al. Usefulness of repeated D-dimer testing after stopping anticoagulation for a first episode of unprovoked venous thromboembolism: the PROLONG II prospective study. , 2010, Blood.
[14] S. Goldhaber,et al. Dabigatran versus warfarin in the treatment of acute venous thromboembolism. , 2009, The New England journal of medicine.
[15] W. Ageno,et al. Residual Thrombosis on Ultrasonography to Guide the Duration of Anticoagulation in Patients With Deep Venous Thrombosis: A Randomized Trial , 2009 .
[16] E. Horváth-Puhó,et al. Arterial cardiovascular events, statins, low‐dose aspirin and subsequent risk of venous thromboembolism: a population‐based case‐control study , 2009, Journal of thrombosis and haemostasis : JTH.
[17] A. Malato,et al. Residual Vein Thrombosis to Establish Duration of Anticoagulation After a First Episode of Deep Vein Thrombosis: The Duration of Anticoagulation Based on Compression UltraSonography (DACUS) Study , 2009 .
[18] J. Douketis,et al. Systematic Review: d-Dimer to Predict Recurrent Disease after Stopping Anticoagulant Therapy for Unprovoked Venous Thromboembolism , 2008, Annals of Internal Medicine.
[19] S. Kahn,et al. Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy , 2008, Canadian Medical Association Journal.
[20] G. Mariani,et al. Residual vein thrombosis to establish duration of anticoagulation after a first episode of deep vein thrombosis: the Duration of Anticoagulation based on Compression UltraSonography (DACUS) study. , 2008, Blood.
[21] G. Guyatt,et al. Physicians Evidence-Based Clinical Practice Development : American College of Chest Thrombolytic Therapy Guideline Methodology for Antithrombotic and , 2008 .
[22] J. Douketis,et al. The Risk for Fatal Pulmonary Embolism after Discontinuing Anticoagulant Therapy for Venous Thromboembolism , 2007, Annals of Internal Medicine.
[23] Paolo Prandoni,et al. The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients. , 2007, Haematologica.
[24] B. Cosmi,et al. D-dimer testing to determine the duration of anticoagulation therapy , 2007 .
[25] M. Prins,et al. Venous thromboembolism and the risk of subsequent symptomatic atherosclerosis , 2006, Journal of thrombosis and haemostasis : JTH.
[26] M. Huisman,et al. Aspirin in the prevention and treatment of venous thromboembolism , 2006 .
[27] E. Minar,et al. The post‐thrombotic syndrome: risk factors and impact on the course of thrombotic disease , 2005, Journal of thrombosis and haemostasis : JTH.
[28] James Douketis,et al. Clinical Impact of Bleeding in Patients Taking Oral Anticoagulant Therapy for Venous Thromboembolism , 2003, Annals of Internal Medicine.
[29] M. Gent,et al. Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism. , 2003, The New England journal of medicine.
[30] P. Ridker,et al. Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism☆ , 2003 .
[31] M. Prins,et al. Residual Venous Thrombosis as a Predictive Factor of Recurrent Venous Thromboembolism , 2002, Annals of Internal Medicine.
[32] Catherine Sudlow,et al. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients , 2002, BMJ : British Medical Journal.
[33] L. Galli,et al. Normalization rates of compression ultrasonography in patients with a first episode of deep vein thrombosis of the lower limbs: association with recurrence and new thrombosis. , 2002, Haematologica.
[34] O. Linder,et al. The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. The Duration of Anticoagulation Trial Study Group. , 1997, The New England journal of medicine.
[35] P. Steele. TRIAL OF DIPYRIDAMOLE-ASPIRIN IN RECURRING VENOUS THROMBOSIS , 1980, The Lancet.